News
-
-
-
COMMUNIQUÉ DE PRESSE
Lindis Blood Care Announces Positive Top-Line Results from Clinical Certification Study REMOVE with CATUVAB® to Enable Autologous Blood Transfusions in Cancer Surgeries
Lindis Blood Care announces positive results from the REMOVE study showcasing the effectiveness of CATUVAB(R) in enabling autologous blood transfusions during cancer surgeries -
-
-
COMMUNIQUÉ DE PRESSE
Lindis Blood Care to Present Top Line Results from Clinical Certification Study REMOVE with CATUVAB® at NATA24 Annual Symposium
Lindis Blood Care to Present Top Line Results from Clinical Certification Study REMOVE with CATUVAB at NATA24 Annual Symposium in Bologna, Italy. Prof. Dr. med. Patrick Meybohm to present safety and efficacy data
